Abstract:BACKGROUND Platelet-vessel wall interaction plays an important role in acute cardiovascular disorders. Thrombin is a potent platelet activator but also has profound effects on the endothelium. Endothelial cells possess antithrombotic activity by releasing nitric oxide and prostacyclin, both potent vasodilators and platelet inhibitors. We studied the role of thrombin as a regulator of platelet-vessel wall interaction in isolated human arteries suspended in organ chambers for isometric tension recording. METHODS AND RESULTS In arteries with endothelium, thrombin (0.01 to 1 U/mL) induced endothelium-dependent relaxations, which were reduced by the nitric oxide synthase inhibitor NG-nitro-L-arginine methyl ester (L-NAME; 10(-4) mol/L) and/or indomethacin (10(-5) mol/L). Human platelets (75,000/microL) evoked only marginal contractions in arteries with endothelium (3 +/- 3% of the contraction to KCl 100 mmol/L; NS), which were markedly enhanced by endothelial removal (22 +/- 4%; P < .05). Thrombin (1 U/mL) did not affect the response to platelets in arteries with (6 +/- 5%; NS) but induced a huge contraction in rings without endothelium (53 +/- 6%; P < .01 versus control without endothelium). The potent contraction to thrombin-activated platelets (1000 to 75,000/microL) in arteries without endothelium was markedly inhibited by the thromboxane A2 synthetase/receptor antagonist ridogrel (10(-5) mol/L; P < .005 versus control) and the single-acting thromboxane receptor blocker SQ-30741 (10(-7) mol/L; P < .01 versus control). CONCLUSIONS Thus, thrombin directly stimulates platelets to release thromboxane A2, inducing potent vasoconstriction, which is prevented by the simultaneous thrombin-induced release of prostacyclin and nitric oxide from endothelial cells. In arteries devoid of functional endothelial cells, as occurs in patients with coronary artery disease, a combined inhibition of thromboxane production and action provides a potent therapeutic tool to interfere with the thrombin-induced activation of platelet-vessel wall interaction.

Thrombin and Vascular Endothelial Cell

Thrombin Disrupts Vascular Endothelial-Cadherin and Leads to Hydrocephalus Via Protease-Activated Receptors-1 Pathway.

Abstract 14982: Rap1 Mediates Thrombin-Induced Vascular Smooth Muscle Cell Proliferation Via an Integrin-Dependent Pathway

Role of thrombospondin-1 and thrombospondin-2 in cardiovascular diseases (Review)

Effects of Puerarin on Thrombin-Induced-proliferation of Vascular Smooth Muscle Cells and the Role of Puerarin on the TR Mrna Expression

Protein Kinase C-related Kinase and ROCK Are Required for Thrombin-induced Endothelial Cell Permeability Downstream from G{alpha}12/13 and G{alpha}11/q

Thrombin-induced endothelium-dependent inhibition and direct activation of platelet-vessel wall interaction. Role of prostacyclin, nitric oxide, and thromboxane A2.

Effects of Thrombin on the Neurovascular Unit in Cerebral Ischemia

The role of vascular endothelial cells in thrombosis caused by biomaterials

Thrombin and malignancy of lung

Hemostatic Protease Receptors and Endothelial Cell Function: Insights from Gene Targeting in Mice

Endothelial Cell Behavior Is Determined by Receptor Clustering Induced by Thrombospondin-1

Rat Brain Capillary Thrombomodulin

Thrombin and Thrombin‐Incorporated Biomaterials for Disease Treatments

Intracerebral hemorrhage and thrombin-induced alterations in cerebral microvessel matrix

Tissue factor (:Factor VIIa) in the heart and vasculature: More than an envelope

Transient Receptor Potential Channels and Endothelial Cell Calcium Signaling

Zyxin is Involved in Thrombin Signalingviainteraction with PAR‐1 Receptor

Thrombin—unique coagulation system protein with multifaceted impacts on cancer and metastasis

The Role of Protein Kinases in Microvascular Permeability

Extracellular Traps and the Role in Thrombosis